Avanos Medical (AVNS) Receivables - Net (2016 - 2025)
Avanos Medical (AVNS) has disclosed Receivables - Net for 13 consecutive years, with $108.0 million as the latest value for Q4 2025.
- Quarterly Receivables - Net fell 18.67% to $108.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $108.0 million through Dec 2025, down 18.67% year-over-year, with the annual reading at $108.0 million for FY2025, 18.67% down from the prior year.
- Receivables - Net hit $108.0 million in Q4 2025 for Avanos Medical, down from $116.0 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $167.9 million in Q4 2022 to a low of $108.0 million in Q4 2025.
- Historically, Receivables - Net has averaged $132.0 million across 5 years, with a median of $131.6 million in 2024.
- Biggest five-year swings in Receivables - Net: tumbled 33.46% in 2021 and later skyrocketed 47.58% in 2022.
- Year by year, Receivables - Net stood at $131.2 million in 2021, then rose by 27.97% to $167.9 million in 2022, then decreased by 14.95% to $142.8 million in 2023, then decreased by 7.0% to $132.8 million in 2024, then decreased by 18.67% to $108.0 million in 2025.
- Business Quant data shows Receivables - Net for AVNS at $108.0 million in Q4 2025, $116.0 million in Q3 2025, and $110.2 million in Q2 2025.